In the Journals

Health care utilization, corticosteroid use higher in patients with asthma, allergic granulomatosis

December 10, 2019
A need exists for treatments for specific eosinophilic granulomatosis with polyangiitis and medications to control symptoms and improve outcomes in…

In the Journals

Innovative clinical trial designs, therapies for refractory disease top unmet needs in rheumatology

December 10, 2019
New treatments and trial designs, particularly focused on patients with refractory disease, remain among the top unmet needs in rheumatology in 2019…

In the Journals

Health-related QoL less impacted in radiographic vs. nonradiographic axial SpA

December 9, 2019
Radiographic axial spondyloarthritis, or axSpA appears to have less impact on patient-reported outcome measures than the nonradiographic form of the…

In the Journals

IL-12/23 inhibitors linked to lower infection risk than TNF, IL-17 inhibitors in PsA, psoriasis

December 9, 2019
Patients with psoriasis or psoriatic arthritis who are newly treated with IL-12/23 blockers demonstrated a reduced risk for serious infection…

FDA News

FDA approves Avsola, fourth Remicade biosimilar

December 6, 2019
The FDA has approved the fourth biosimilar to infliximab, infliximab-axxq, for all eligible indications of the biologic product. Avsola…

Feature

Podcasts driving a revolution in rheumatology medical education

December 6, 2019
When journalist Ben Hammersley coined the word “podcast” in 2004, he was attempting to put a name to the phenomenon resulting from the…

In the Journals

ACR, EULAR release first classification criteria for IgG4

December 4, 2019
The American College of Rheumatology and EULAR have officially released the first classification criteria for IgG4-related disease, emphasizing…

In the JournalsPerspective

Apremilast reduces number of Behçet's-related oral ulcers

December 4, 2019
Treatment with apremilast resulted in a greater reduction in the number of oral ulcers related to Behçet’s syndrome, compared with placebo, but…

In the Journals

Symptoms, imaging abnormalities differ in patients with TAK, GCA

December 3, 2019
Among patients with Takayasu’s and giant cell arteritis, certain symptoms, such as carotidynia, are more closely associated with vascular…

In the JournalsPerspective

EULAR: Immunosuppressant use only to spare steroids in Sjögren’s syndrome

December 2, 2019
Rheumatologists treating patients with systemic Sjögren’s syndrome should tailor their therapies to organ-specific severity, with…

Meeting News

One-year delay in diagnosis common for Down syndrome arthropathy

November 29, 2019
ATLANTA — Patients with Down syndrome arthropathy experience a year-long delay from symptom onset to diagnosis, according to a presentation at…

Meeting News

Scarcity of lupus assays in developing countries limit utility of international criteria, trials

November 27, 2019
ATLANTA — Limited access to supportive laboratory assays in developing countries significantly reduces the diagnostic utility of the ACR/EULAR…

Meeting News

RA remission with abatacept, methotrexate best maintained by continued treatment

November 27, 2019
ATLANTA — Among patients with early rheumatoid arthritis who are positive for anti-citrullinated protein antibodies, and achieve remission with…

Meeting News

Lorecivivint yields improved patient-reported outcome scores in knee OA

November 27, 2019
ATLANTA — A 0.07 mg intra-articular injection of lorecivivint, a Wnt pathway inhibitor, was associated with improvements in patient-reported…

Meeting News

TULIP-1: Anifrolumab fails primary endpoint, confers clinical benefit in SLE

November 26, 2019
ATLANTA — Although a 300 mg dose of anifrolumab failed to meet the primary endpoint of systemic lupus erythematosus responder index, a post-hoc…

Meeting News

ADA2 levels elevated in systemic JIA with macrophage activation syndrome

November 26, 2019
ATLANTA — Systemic juvenile idiopathic arthritis with macrophage activation syndrome was marked by elevated adenosine deaminase 2 levels…

Meeting NewsPerspective

Absence of pediatric studies blocking critical biologic DMARDs for JIA

November 25, 2019
ATLANTA — Lax FDA policies on required pediatric studies for approved biologic DMARDs have exacerbated an already critical lack of approved…

Meeting News

Study finds pathway for UVB light exposure as trigger for flares in SLE

November 25, 2019
ATLANTA — Upregulation of the cGAS-STING pathway may be implicated in disease flares of systemic lupus erythematosus that are triggered by…

Meeting News

Lupus Foundation of America encourages patient self-management

November 22, 2019
ATLANTA — The Lupus Foundation of America conducted two studies that aimed to help patients feel empowered and motivated to self-manage their…

Meeting News

Despite flare prevalence with checkpoint inhibitors, patients with RA rarely discontinue

November 22, 2019
ATLANTA — Although disease flares were common among patients with rheumatoid arthritis who received immune checkpoint inhibitors to treat…